250
Participants
Start Date
November 15, 2023
Primary Completion Date
August 31, 2024
Study Completion Date
August 31, 2024
Travoprost Ophthalmic Topical Cream low-dose
travoprost ophthalmic topical cream low-dose once daily in the evening to both eyes
Travoprost Ophthalmic Topical Cream mid-dose
travoprost ophthalmic topical cream mid-dose once daily in the evening to both eyes
Travoprost Ophthalmic Topical Cream high-dose
travoprost ophthalmic topical cream high-dose once daily in the evening to both eyes
Timolol maleate ophthalmic solution, 0.5%
timolol maleate ophthalmic solution, 0.5% twice daily (morning \& evening) to both eyes
Travoprost Ophthalmic Solution, 0.004%
travoprost ophthalmic solution, 0.004% once daily in the evening to both eyes
RECRUITING
Glaukos Clinical Study Site, Newport Beach
Lead Sponsor
Glaukos Corporation
INDUSTRY